DCTH Valuation

Delcath Systems Inc

Add to Watchlist

Advanced Chart

11.550

+0.01(0.087%)1D

Overview
Forecast
Valuation
Earnings

DCTH Relative Valuation

DCTH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DCTH is overvalued; if below, it's undervalued.

Historical Valuation

Delcath Systems Inc (DCTH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -6.92. The fair price of Delcath Systems Inc (DCTH) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 11.55 USD , Delcath Systems Inc is Undervalued By Fair.

Relative Value

Fair Zone

+Inf-+Inf

Current Price：11.55

Fair

Undervalued

65.37

Trailing

Forward

12.59

EV/EBITDA

Delcath Systems Inc. (DCTH) has a current EV/EBITDA of 12.59. The 5-year average EV/EBITDA is -6.65. The thresholds are as follows: Strongly Undervalued below -63.00, Undervalued between -63.00 and -34.83, Fairly Valued between 21.53 and -34.83, Overvalued between 21.53 and 49.70, and Strongly Overvalued above 49.70. The current Forward EV/EBITDA of 12.59 falls within the Historic Trend Line -Fairly Valued range.

79.85

EV/EBIT

Delcath Systems Inc. (DCTH) has a current EV/EBIT of 79.85. The 5-year average EV/EBIT is -26.70. The thresholds are as follows: Strongly Undervalued below -334.04, Undervalued between -334.04 and -180.37, Fairly Valued between 126.97 and -180.37, Overvalued between 126.97 and 280.64, and Strongly Overvalued above 280.64. The current Forward EV/EBIT of 79.85 falls within the Historic Trend Line -Fairly Valued range.

3.58

Delcath Systems Inc. (DCTH) has a current PS of 3.58. The 5-year average PS is 16.36. The thresholds are as follows: Strongly Undervalued below -15.65, Undervalued between -15.65 and 0.35, Fairly Valued between 32.36 and 0.35, Overvalued between 32.36 and 48.37, and Strongly Overvalued above 48.37. The current Forward PS of 3.58 falls within the Historic Trend Line -Fairly Valued range.

18.39

P/OCF

Delcath Systems Inc. (DCTH) has a current P/OCF of 18.39. The 5-year average P/OCF is -2.98. The thresholds are as follows: Strongly Undervalued below -489.01, Undervalued between -489.01 and -246.00, Fairly Valued between 240.03 and -246.00, Overvalued between 240.03 and 483.05, and Strongly Overvalued above 483.05. The current Forward P/OCF of 18.39 falls within the Historic Trend Line -Fairly Valued range.

19.69

P/FCF

Delcath Systems Inc. (DCTH) has a current P/FCF of 19.69. The 5-year average P/FCF is 12.82. The thresholds are as follows: Strongly Undervalued below -133.65, Undervalued between -133.65 and -60.42, Fairly Valued between 86.06 and -60.42, Overvalued between 86.06 and 159.30, and Strongly Overvalued above 159.30. The current Forward P/FCF of 19.69 falls within the Historic Trend Line -Fairly Valued range.

Delcath Systems Inc (DCTH) has a current Price-to-Book (P/B) ratio of 3.85. Compared to its 3-year average P/B ratio of -13.17 , the current P/B ratio is approximately -129.20% higher. Relative to its 5-year average P/B ratio of -5.92, the current P/B ratio is about -164.94% higher. Delcath Systems Inc (DCTH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -31.14%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -35.59% , the current FCF yield is about -100.00% lower.

3.85

P/B

Median3y

-13.17

Median5y

-5.92

0.96

FCF Yield

Median3y

-31.14

Median5y

-35.59

Competitors Valuation Multiple

The average P/S ratio for DCTH's competitors is 1.33, providing a benchmark for relative valuation. Delcath Systems Inc Corp (DCTH) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 211.05%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Mesa Laboratories Inc

AirSculpt Technologies Inc

Pacific Biosciences of California Inc

Semler Scientific Inc

Loss

-43.19%

474.64M

Performance Decomposition

Market capitalization of DCTH increased by 31.58% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 7.77M to 24.16M.

The secondary factor is the P/E Change, contributed -73.16%to the performance.

Overall, the performance of DCTH in the past 1 year is driven by Revenue Growth. Which is more sustainable.

211.05%

7.77M → 24.16M

Revenue Growth

-106.31%

-176.94 → 11.16

Margin Expansion

-73.16%

769.14 → 206.44

P/E Change

31.58%